Lifting the mood with ketamine

被引：23

作者：

Murrough, James W. ^{[1
]}

Charney, Dennis S. ^{[2
]}

机构：

[1] Mt Sinai Sch Med, Mood & Anxiety Disorders Program, New York, NY USA

[2] Mt Sinai Sch Med, Off Dean, New York, NY USA

来源：

NATURE MEDICINE | 2010年 / 16卷 / 12期

关键词：

D-ASPARTATE ANTAGONIST; ANTIDEPRESSANT; DEPRESSION; RECEPTORS;

D O I：

10.1038/nm1210-1384

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页码：1384 / 1385

页数：2

共 12 条

[1] Antidepressant effects of ketamine in depressed patients [J].

Berman, RM ;

Cappiello, A ;

Anand, A ;

Oren, DA ;

Heninger, GR ;

Charney, DS ;

Krystal, JH .

BIOLOGICAL PSYCHIATRY, 2000, 47 (04) :351-354

[2] mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists [J].

Li, Nanxin ;

Lee, Boyoung ;

Liu, Rong-Jian ;

Banasr, Mounira ;

Dwyer, Jason M. ;

Iwata, Masaaki ;

Li, Xiao-Yuan ;

Aghajanian, George ;

Duman, Ronald S. .

SCIENCE, 2010, 329 (5994) :959-964

[3] Cellular mechanisms underlying the antidepressant effects of ketamine:: Role of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors [J].

Maeng, Sungho ;

Zarate, Carlos A., Jr. ;

Du, Jing ;

Schloesser, Robert J. ;

McCammon, Joseph ;

Chen, Guang ;

Manji, Husseini K. .

BIOLOGICAL PSYCHIATRY, 2008, 63 (04) :349-352

[4] Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial [J].

Mathew, Sanjay J. ;

Murrough, James W. ;

aan het Rot, Marije ;

Collins, Katherine A. ;

Reich, David L. ;

Charney, Dennis S. .

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 (01) :71-82

[5] PATHOLOGICAL-CHANGES INDUCED IN CEREBROCORTICAL NEURONS BY PHENCYCLIDINE AND RELATED DRUGS [J].

OLNEY, JW ;

LABRUYERE, J ;

PRICE, MT .

SCIENCE, 1989, 244 (4910) :1360-1362

[6] Psychiatric safety of ketamine in psychopharmacology research [J].

Perry, Edward B., Jr. ;

Cramer, Joyce A. ;

Cho, Hyun-Sang ;

Petrakis, Ismene L. ;

Karper, Laurence P. ;

Genovese, Angelina ;

O'Donnell, Elizabeth ;

Krystal, John H. ;

D'Souza, D. Cyril .

PSYCHOPHARMACOLOGY, 2007, 192 (02) :253-260

[7] An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder [J].

Preskorn, Sheldon H. ;

Baker, Bryan ;

Kolluri, Sheela ;

Menniti, Frank S. ;

Krams, Michael ;

Landen, Jaren W. .

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (06) :631-637

[8] Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant Depression [J].

Price, Rebecca B. ;

Nock, Matthew K. ;

Charney, Dennis S. ;

Mathew, Sanjay J. .

BIOLOGICAL PSYCHIATRY, 2009, 66 (05) :522-526

[9]

ROT MAH, 2010, BIOL PSYCHIAT, V67, P139, DOI DOI 10.1016/J.BIOPSYCH.2009.08.038

[10] Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: Implications for the pharmacotherapy of depression [J].

Skolnick, P ;

Layer, RT ;

Popik, P ;

Nowak, G ;

Paul, IA ;

Trullas, R .

PHARMACOPSYCHIATRY, 1996, 29 (01) :23-26

← 1 2 →